Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer
ClinicalTrials.gov study NCT03762161. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
ClinicalTrials.gov study NCT06247956. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
ClinicalTrials.gov study NCT05312671. IPD Sharing: NO. Countries: 1. Publications: 0.
Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT05736952. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
ClinicalTrials.gov study NCT02188550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cance
ClinicalTrials.gov study NCT06694454. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
ClinicalTrials.gov study NCT07200947. IPD Sharing: NO. Countries: 1. Publications: 0.
A PHASE II, RANDOMIZED TRIAL TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT VULVAR CANCER
ClinicalTrials.gov study NCT07101848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00047801. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
ClinicalTrials.gov study NCT04374630. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
ClinicalTrials.gov study NCT06856213. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT07314619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
ClinicalTrials.gov study NCT06463665. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
ClinicalTrials.gov study NCT07178795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT06888921. IPD Sharing: YES. Countries: 3. Publications: 0.
Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01388621. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors
ClinicalTrials.gov study NCT03726281. IPD Sharing: YES. Countries: 1. Publications: 0.
Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05756907. IPD Sharing: NO. Countries: 2. Publications: 0.
Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
ClinicalTrials.gov study NCT06439225. IPD Sharing: YES. Countries: 1. Publications: 0.
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT00097409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.